Bayer faces second trial over Roundup weedkiller most cancers dangers

breaking news Pakistan

A subsidiary of German pharmaceutical big Bayer faces a second trial on Monday over accusations that its glyphosate-based weedkiller Roundup causes most cancers.

A court docket in San Francisco is to find out whether or not California resident Edwin Hardeman’s most cancers was attributable to a weedkiller produced by Monsanto, which has been a unit of Bayer since a takeover final yr.

It’s also a check case for hundreds of Roundup circumstances nationwide. Greater than 760 circumstances are consolidated within the San Francisco court docket listening to Hardeman’s case.

Monday’s session will start with opening statements, and witness testimony is predicted to take between 4 and 5 weeks.

The trial comes six months after one other California court docket discovered that Roundup had triggered one other man’s non-Hodgkin’s lymphoma and that Monsanto had did not warn customers in regards to the most cancers dangers.